OrbiMed

United States
Firm Location:United States • New Jersey • New York, New York • Chicago, Illinois • Philadelphia, Pennsylvania • San Francisco, California • Bellevue, Washington • Boulder, Colorado • Hoboken, New Jersey • Beijing • Hong Kong • San Francisco Bay Area • Israel
OrbiMed Team
Photo of Mona Ashiya, Partner at OrbiMed
Mona Ashiya
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in New York City (Other Lists)
Photo of David Bonita, General Partner at OrbiMed
David Bonita
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Sven Borho, Managing Partner at OrbiMed
Sven Borho
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Evan Caplan, Principal at OrbiMed
Evan Caplan
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in SF Bay Area (CA)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of Iain Dukes, Venture Partner at OrbiMed
Iain Dukes
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Michael Eggenberg, Managing Director at OrbiMed
Michael Eggenberg
OrbiMed·Managing Director
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in United States
Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT
Photo of Lars Enstrom, Managing Director at OrbiMed
Lars Enstrom
OrbiMed·Managing Director
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Robert Glassman, Venture Partner at OrbiMed
Robert Glassman
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Carl  Gordon, Managing Partner at OrbiMed
Carl Gordon
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Rishi Gupta, Partner at OrbiMed
Rishi Gupta
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in San Francisco (CA)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of Sevgi Gurkan, Venture Partner at OrbiMed
Sevgi Gurkan
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in SF Bay Area (CA)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of Geoffrey Hsu, General Partner at OrbiMed
Geoffrey Hsu
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Alexandria Huynh, Analyst at OrbiMed
Alexandria Huynh
OrbiMed·Analyst
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in New York City (Other Lists)
Photo of Mark Jelley, Managing Director at OrbiMed
Mark Jelley
OrbiMed·Managing Director
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Chau Khuong, Partner at OrbiMed
Chau Khuong
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Kip Kitur, Senior Associate at OrbiMed
Kip Kitur
OrbiMed·Senior Associate
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Kevin Koch, Venture Partner at OrbiMed
Kevin Koch
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in San Francisco (CA), Investors in New York
Investors in BioTech, Investors in BioTech, Investors in Colorado / Utah (Other Lists), Investors in Diagnostics, Investors in Diagnostics, Investors in Medical Devices, Investors in Medical Devices
Photo of Dimitri Krainc, Venture Partner at OrbiMed
Dimitri Krainc
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Chicago (IL)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Midwest (Other Lists)
Photo of Jonathan Lee, Analyst at OrbiMed
Jonathan Lee
OrbiMed·Analyst
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists)
Photo of Jonathan Mandelbaum, Senior Associate at OrbiMed
Jonathan Mandelbaum
OrbiMed·Senior Associate
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of W. Carter Neild, Managing Partner at OrbiMed
W. Carter Neild
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Anat Nursella, Venture Partner at OrbiMed
Anat Nursella
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Israel
Investors in BioTech, Investors in BioTech, Investors in Israel (Other Lists)
Photo of Topher Orr, Analyst at OrbiMed
Topher Orr
OrbiMed·Analyst
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists)
Photo of Trevor Polischuk, Partner at OrbiMed
Trevor Polischuk
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of William Price, Managing Director at OrbiMed
William Price
OrbiMed·Managing Director
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Matthew Rizzo, Partner at OrbiMed
Matthew Rizzo
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of William Sawyer, Partner at OrbiMed
William Sawyer
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Natasha Shervani, Senior Associate at OrbiMed
Natasha Shervani
OrbiMed·Senior Associate
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York City
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Vivek Sivathanu, Senior Associate at OrbiMed
Vivek Sivathanu
OrbiMed·Senior Associate
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Stephen Squinto, Partner at OrbiMed
Stephen Squinto
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Charles Steinman, Analyst at OrbiMed
Charles Steinman
OrbiMed·Analyst
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists)
Photo of C. Scotland Stevens, General Partner at OrbiMed
C. Scotland Stevens
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Jim Sullivan, Venture Partner at OrbiMed
Jim Sullivan
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Midwest (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Peter Thompson, Partner at OrbiMed
Peter Thompson
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY), Investors in San Francisco (CA)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in Seattle / Portland (Other Lists)
Photo of Klaus Veitinger, Venture Partner at OrbiMed
Klaus Veitinger
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Iris Wang, Partner at OrbiMed
Iris Wang
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in Hong Kong
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Steven Wang, Partner at OrbiMed
Steven Wang
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in China, Investors in Shanghai
Investors in BioTech, Investors in BioTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Conrad Wang, Principal at OrbiMed
Conrad Wang
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Brendan Weber, Vice President at OrbiMed
Brendan Weber
OrbiMed·Vice President
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in United States, Investors in New Jersey
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)
Photo of Diyong Xu, Principal at OrbiMed
Diyong Xu
OrbiMed·Principal
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Nate Yee, Vice President at OrbiMed
Nate Yee
OrbiMed·Vice President
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Digital Health, Investors in Digital Health, Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists)